BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 25623836)

  • 1. Persistence and pathogenesis of the neurotropic polyomavirus JC.
    Wollebo HS; White MK; Gordon J; Berger JR; Khalili K
    Ann Neurol; 2015 Apr; 77(4):560-70. PubMed ID: 25623836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic assays for polyomavirus JC and progressive multifocal leukoencephalopathy.
    White MK; Sariyer IK; Gordon J; Delbue S; Pietropaolo V; Berger JR; Khalili K
    Rev Med Virol; 2016 Mar; 26(2):102-14. PubMed ID: 26663440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neurological complications of JC virus infection: A review].
    Moulignier A; Lecler A
    Rev Med Interne; 2021 Mar; 42(3):177-185. PubMed ID: 33168355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunology of progressive multifocal leukoencephalopathy.
    Jelcic I; Jelcic I; Faigle W; Sospedra M; Martin R
    J Neurovirol; 2015 Dec; 21(6):614-22. PubMed ID: 25740538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular biology and immunoregulation of human neurotropic JC virus in CNS.
    Sweet TM; Del Valle L; Khalili K
    J Cell Physiol; 2002 Jun; 191(3):249-56. PubMed ID: 12012320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.
    Bellizzi A; Nardis C; Anzivino E; Rodìo D; Fioriti D; Mischitelli M; Chiarini F; Pietropaolo V
    J Neurovirol; 2012 Feb; 18(1):1-11. PubMed ID: 22290500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Progressive multifocal leukoencephalopathy].
    Moulignier A; Lecler A; Lamirel C
    Rev Prat; 2016 Feb; 66(2):185-190. PubMed ID: 30512335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Host-Immune Interactions in JC Virus Reactivation and Development of Progressive Multifocal Leukoencephalopathy (PML).
    Khalili A; Craigie M; Donadoni M; Sariyer IK
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):649-660. PubMed ID: 31452013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune surveillance and response to JC virus infection and PML.
    Beltrami S; Gordon J
    J Neurovirol; 2014 Apr; 20(2):137-49. PubMed ID: 24297501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of the JC Virus in Central Nervous System Tumorigenesis.
    Ahye N; Bellizzi A; May D; Wollebo HS
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of progressive multifocal leukoencephalopathy--revisited.
    White MK; Khalili K
    J Infect Dis; 2011 Mar; 203(5):578-86. PubMed ID: 21227915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. History and current concepts in the pathogenesis of PML.
    Major EO
    Cleve Clin J Med; 2011 Nov; 78 Suppl 2():S3-7. PubMed ID: 22123932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?
    Diotti RA; Nakanishi A; Clementi N; Mancini N; Criscuolo E; Solforosi L; Clementi M
    Clin Dev Immunol; 2013; 2013():967581. PubMed ID: 23878587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that the soluble factors secreted by activated immune cells suppress replication of human neurotropic JC virus DNA in glial cells.
    Chang CF; Otte J; Kerr DA; Välkkilä M; Calkins CE; Khalili K
    Virology; 1996 Jul; 221(1):226-31. PubMed ID: 8661431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of immune escape in central nervous system infection with neurotropic JC virus variant.
    Jelcic I; Jelcic I; Kempf C; Largey F; Planas R; Schippling S; Budka H; Sospedra M; Martin R
    Ann Neurol; 2016 Mar; 79(3):404-18. PubMed ID: 26874214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progressive multifocal leukoencephalopathy and other disorders caused by JC virus: clinical features and pathogenesis.
    Tan CS; Koralnik IJ
    Lancet Neurol; 2010 Apr; 9(4):425-37. PubMed ID: 20298966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JC Polyomavirus, progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome: a review.
    Harypursat V; Zhou Y; Tang S; Chen Y
    AIDS Res Ther; 2020 Jul; 17(1):37. PubMed ID: 32631361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy.
    Du Pasquier RA; Kuroda MJ; Zheng Y; Jean-Jacques J; Letvin NL; Koralnik IJ
    Brain; 2004 Sep; 127(Pt 9):1970-8. PubMed ID: 15215217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of JC virus in two African cases of progressive multifocal leukoencephalopathy including identification of JCV type 3 in a Gambian AIDS patient.
    Stoner GL; Agostini HT; Ryschkewitsch CF; Mazló M; Gullotta F; Wamukota W; Lucas S
    J Med Microbiol; 1998 Aug; 47(8):733-42. PubMed ID: 9877195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A second-generation ELISA (STRATIFY JCV™ DxSelect™) for detection of JC virus antibodies in human serum and plasma to support progressive multifocal leukoencephalopathy risk stratification.
    Lee P; Plavina T; Castro A; Berman M; Jaiswal D; Rivas S; Schlain B; Subramanyam M
    J Clin Virol; 2013 Jun; 57(2):141-6. PubMed ID: 23465394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.